Literature DB >> 11401925

Colonic mucosal concentrations of folate are accurately predicted by blood measurements of folate status among individuals ingesting physiologic quantities of folate.

Y I Kim1, K Fawaz, T Knox, Y M Lee, R Norton, E Libby, J B Mason.   

Abstract

Folate status is inversely related to the risk of colorectal cancer. Whether conventional blood measurements of folate status accurately reflect folate concentrations in the colorectal mucosa has been a controversial topic. This is an important issue because accurate measures of folate status in the colorectal mucosa are important for ascertaining the risk of colorectal cancer in epidemiological studies and for determining the effects of folate supplementation in clinical trials. We examined whether conventional blood measurements of folate and a more sensitive, inverse indicator of systemic folate status, serum homocysteine, accurately reflect folate concentrations in human colonic mucosa obtained by endoscopic biopsy. Study subjects (n = 20) were participants in a randomized trial that investigated the effect of folate supplementation (5 mg daily for 1 year) on provisional molecular markers of colon cancer. Blood samples and biopsies of normal rectosigmoid mucosa were obtained at baseline, at 6 months, and at 1 year. Serum, RBC, and colonic mucosal folate and serum homocysteine concentrations were determined. Colonic mucosal folate concentrations correlated directly with serum folate concentrators at each time point (r = 0.572-0.845; P < 0.015) and with RBC folate concentrations at 6 months and 1 year (r = 0.747-0.771; P < 0.001). Colonic mucosal folate concentrations correlated inversely with serum homocysteine concentrations at each time point (r = -0.622-0.666; P < 0.008). Systemic measures of folate status did not correlate with colonic mucosal folate concentrations among individuals receiving supplemental folate. Our observations indicate that colonic mucosal concentrations of folate may be predicted accurately by blood measurements of folate status only among individuals not ingesting supraphysiological quantities of folate.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11401925

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  9 in total

1.  Mathematical modeling predicts the effect of folate deficiency and excess on cancer-related biomarkers.

Authors:  Marian L Neuhouser; H Frederik Nijhout; Jesse F Gregory; Michael C Reed; S Jill James; Amy Liu; Barry Shane; Cornelia M Ulrich
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-07-13       Impact factor: 4.254

2.  Baseline plasma total homocysteine and adenoma recurrence: results from a double blind randomized clinical trial of aspirin and folate supplementation.

Authors:  A Joan Levine; Maria V Grau; Leila A Mott; Per Magne Ueland; John A Baron
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-09-14       Impact factor: 4.254

3.  Altered folate availability modifies the molecular environment of the human colorectum: implications for colorectal carcinogenesis.

Authors:  Petr Protiva; Joel B Mason; Zhenhua Liu; Michael E Hopkins; Celeste Nelson; James R Marshall; Richard W Lambrecht; Swaroop Pendyala; Levy Kopelovich; Myungjin Kim; Steven H Kleinstein; Peter W Laird; Martin Lipkin; Peter R Holt
Journal:  Cancer Prev Res (Phila)       Date:  2011-02-14

4.  Concentration of folate in colorectal tissue biopsies predicts prevalence of adenomatous polyps.

Authors:  Andrew Flood; Joel B Mason; Zhenhua Liu; Brooks D Cash; Arthur Schatzkin; Philip S Schoenfeld; Amanda J Cross
Journal:  Gut       Date:  2010-11-10       Impact factor: 23.059

5.  Methylenetetrahydrofolate reductase C677T genotype affects promoter methylation of tumor-specific genes in sporadic colorectal cancer through an interaction with folate/vitamin B12 status.

Authors:  Pooneh Mokarram; Fakhraddin Naghibalhossaini; Mehdi Saberi Firoozi; Seyed Vahid Hosseini; Ahmad Izadpanah; Heshmetalah Salahi; Seyed Ali Malek-Hosseini; Abdoulrasool Talei; Mehra Mojallal
Journal:  World J Gastroenterol       Date:  2008-06-21       Impact factor: 5.742

6.  Colorectal adenomas in a randomized folate trial: the role of baseline dietary and circulating folate levels.

Authors:  Jane C Figueiredo; A Joan Levine; Maria V Grau; Elizabeth L Barry; Per M Ueland; Dennis J Ahnen; Tim Byers; Robert S Bresalier; Robert W Summers; John Bond; Gail E McKeown-Eyssen; Robert S Sandler; Robert W Haile; John A Baron
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-10       Impact factor: 4.254

7.  Placental dysfunction is associated with altered microRNA expression in pregnant women with low folate status.

Authors:  Bernadette C Baker; Fiona L Mackie; Samantha C Lean; Susan L Greenwood; Alexander E P Heazell; Karen Forbes; Rebecca L Jones
Journal:  Mol Nutr Food Res       Date:  2017-03-21       Impact factor: 5.914

Review 8.  Interaction between Metformin, Folate and Vitamin B12 and the Potential Impact on Fetal Growth and Long-Term Metabolic Health in Diabetic Pregnancies.

Authors:  Manon D Owen; Bernadette C Baker; Eleanor M Scott; Karen Forbes
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

9.  The association between MTHFR 677C>T genotype and folate status and genomic and gene-specific DNA methylation in the colon of individuals without colorectal neoplasia.

Authors:  Joanna Hanks; Iyeman Ayed; Neil Kukreja; Chris Rogers; Jessica Harris; Alina Gheorghiu; Chee Ling Liu; Peter Emery; Maria Pufulete
Journal:  Am J Clin Nutr       Date:  2013-10-09       Impact factor: 7.045

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.